LY3454738
18569
Phase 2 small_molecule terminated
Quick answer
LY3454738 for Atopic Dermatitis is a Phase 2 program (small_molecule) at Eli Lilly and Company with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Eli Lilly and Company
- Indication
- Atopic Dermatitis
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- terminated